Healthcare Realty Trust Incorporated (NYSE:HR) Stock Holdings Lowered by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. lowered its position in shares of Healthcare Realty Trust Incorporated (NYSE:HR) by 18.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 45,901 shares of the real estate investment trust’s stock after selling 10,170 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Healthcare Realty Trust were worth $778,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Bank of New York Mellon Corp grew its position in Healthcare Realty Trust by 12.0% in the 4th quarter. Bank of New York Mellon Corp now owns 4,630,973 shares of the real estate investment trust’s stock valued at $78,495,000 after buying an additional 495,599 shares in the last quarter. Impax Asset Management Group plc grew its position in Healthcare Realty Trust by 10.0% in the 4th quarter. Impax Asset Management Group plc now owns 440,000 shares of the real estate investment trust’s stock valued at $7,458,000 after buying an additional 40,000 shares in the last quarter. Hudson Edge Investment Partners Inc. grew its position in Healthcare Realty Trust by 22.1% in the 4th quarter. Hudson Edge Investment Partners Inc. now owns 39,185 shares of the real estate investment trust’s stock valued at $664,000 after buying an additional 7,101 shares in the last quarter. Ieq Capital LLC bought a new position in Healthcare Realty Trust in the 4th quarter valued at about $659,000. Finally, New York State Common Retirement Fund grew its position in Healthcare Realty Trust by 131.8% in the 4th quarter. New York State Common Retirement Fund now owns 386,679 shares of the real estate investment trust’s stock valued at $6,554,000 after buying an additional 219,848 shares in the last quarter.

Healthcare Realty Trust Trading Down 0.6 %

HR stock opened at $16.69 on Wednesday. Healthcare Realty Trust Incorporated has a one year low of $12.77 and a one year high of $18.90. The firm has a market capitalization of $5.86 billion, a PE ratio of -9.38 and a beta of 0.94. The firm has a 50-day moving average of $16.63 and a two-hundred day moving average of $17.36.

Healthcare Realty Trust (NYSE:HR) last posted its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. Healthcare Realty Trust had a negative net margin of 51.60% and a negative return on equity of 11.20%. The company had revenue of $309.77 million during the quarter, compared to analyst estimates of $303.81 million. During the same period in the prior year, the firm earned $0.39 earnings per share. The business’s quarterly revenue was down 6.3% on a year-over-year basis. On average, equities research analysts anticipate that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current year.

Healthcare Realty Trust Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 19th. Shareholders of record on Monday, March 3rd will be paid a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 7.43%. The ex-dividend date is Monday, March 3rd. Healthcare Realty Trust’s dividend payout ratio is presently -69.66%.

Analyst Ratings Changes

A number of brokerages recently issued reports on HR. Scotiabank decreased their target price on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a “sector perform” rating for the company in a research report on Tuesday, February 25th. StockNews.com lowered shares of Healthcare Realty Trust from a “hold” rating to a “sell” rating in a research report on Wednesday. Jefferies Financial Group lowered shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and reduced their price objective for the company from $19.00 to $17.00 in a research report on Thursday, January 2nd. JPMorgan Chase & Co. lowered shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price objective for the company. in a research report on Friday, December 20th. Finally, Wedbush restated an “outperform” rating and set a $16.00 price objective on shares of Healthcare Realty Trust in a research report on Thursday, February 20th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $17.20.

Insider Transactions at Healthcare Realty Trust

In related news, COO Robert E. Hull sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $17.48, for a total transaction of $174,800.00. Following the completion of the sale, the chief operating officer now directly owns 171,400 shares in the company, valued at approximately $2,996,072. This trade represents a 5.51 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.56% of the stock is owned by insiders.

Healthcare Realty Trust Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.